The double digit growth registered by the Life Sciences and Healthcare (LSHC) industry in India can be attributed to a number of socio-economic factors. Some of these include, improving health awareness, increasing affluence, changing lifestyles resulting in higher incidence of lifestyle diseases, increasing government expenditure on healthcare and a nascent, yet fast growing health insurance industry. While the sector continues to look up, it is not free of challenges. Poor regulatory enforcement, inadequate healthcare infrastructure, shortage of a skilled workforce, increasing patient expectations and ever-changing technology, act as critical barriers in delivering healthcare services in a sustainable manner.
Our understanding of these opportunities and challenges, and our ability to quickly respond with integrated and comprehensive solutions, put us in a unique position to help. Our LSHC industry specialists work across the breadth of the industry value chain, serving local and global clients in private, public and PPP (Public Private Partnership) space. Our clients span across:
Deloitte brings the right combination of expertise, perspective and strategy, to help our global and local clients realise the opportunities and meet the challenges shaping the LSHC sector. Our LSHC industry group practitioners offer deep industry expertise and follow an integrated and collaborative approach to service, providing clients with executable strategy recommendations and implementation assistance.
|Sustainable Strategies for a Healthy India:Imperatives for Consolidating the Healthcare Management Ecosystem: The striking feature of the sector is that it has the potential to grow at an exponential rate in the foreseeable future and to present new opportunities within itself, which will emerge as growth drivers.|
|Medical Technology industry in India: Currently, the market for medical technology in India is small, but rapidly expanding. It is nascent and highly fragmented with limited indigenous manufacturing - imports constitute over 75% of the estimated US$2.75 billion market.|
|The Right Spice | Pharmaceutical Market Entry in India: This paper sets out to address the questions and concerns of multinational pharmaceutical manufacturers contemplating entry and growth in India as a market for their products.|
|Can Healthcare Rescue Real Estate? | Assessing the Potential Impact of Healthcare Reform on Commercial Real Estate: This paper highlights several trends already underway within the healthcare sector that are forecasted to have a positive trajectory over the next few years.|
|“Shared” services for life sciences companies | A prescription for value: Today as never before, life sciences companies must use every possible means to reduce their costs and increase their efficiency. An effective shared model to deliver functional and business support services can be an excellent way to achieve these goals.|
|Executing and sustaining R&D strategy in Life Sciences : This article describes how R&D organizations can become more effective in the execution of strategies and demonstrates how this would increase the likelihood of achieving the expected, lasting benefits of their strategies.|